Stay updated on CBCV Individualized Vaccine for HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the CBCV Individualized Vaccine for HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CBCV Individualized Vaccine for HR+ Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:44:59.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a trial testing focal hypo-fractionated RT alone or with immunotherapy combinations for newly diagnosed post-menopausal women with clinical stage II-III, HR+HER2- breast cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:51:49.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change includes examples of eligibility criteria such as a person's general health condition or prior treatments, and provides a link for general information about clinical research.
    Difference
    38%
    Check dated 2024-05-22T21:38:07.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:29:19.000Z thumbnail image

Stay in the know with updates to CBCV Individualized Vaccine for HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CBCV Individualized Vaccine for HR+ Breast Cancer Clinical Trial page.